Regenosca is accepted into the SFITS Accelerator Program

Lausanne, Switzerland – January 30, 2025 – Regenosca is proud to announce its acceptance into the SFITS (Swiss Foundation for Innovation and Training in Surgery) Accelerator Program.

This milestone marks an important step in Regenosca’s mission to advance natural, regenerative surgical solutions. Through the SFITS accelerator, Regenosca will benefit from close collaboration with leading surgeons, clinical experts, and industry partners, accelerating the clinical translation and impact of its TissueSpan™ platform, with an initial focus on reconstructive urology.

Participation in SFITS provides Regenosca with a unique ecosystem combining clinical insight, surgical innovation, and entrepreneurship, reinforcing the company’s path toward meaningful improvements in patient care.

We are grateful to the SFITS team for their trust and support, and we look forward to the next phase of growth and collaboration.